Explore the vast range of titles available.

Background Tsetse-transmitted trypanosomiasis severely hampers livestock productivity in Africa, imposing significant economic and health challenges. Traditional trypanocidal treatments are limited by toxicity and emerging drug resistance. Recent interest has focused on use of ethnoveterinary medicines like Aloe vera (AV) which are known for their medicinal and potential antitrypanosomal properties. This study was designed to evaluate the combined effects of diminazene aceturate (DA) and Aloe vera gel (AVG) on parasitemia, serum chemistry, physiological parameters, and hematological profiles in West African Dwarf Goats (WADG) infected with Trypanosoma congolense . Results Sixteen adult goats were randomly allocated into four groups (A–D) of four animals each. Groups B, C, and D were infected intraperitoneally with 3.0 × 10 6 /mL trypanosomes, while Group A served as the uninfected control. Two weeks post-infection, Group C received 3.5 mg/kg DA alone, and Group D received 3.5 mg/kg DA in combination with 1.2 ml/kg AVG; Group B remained untreated. Treatment was successful in both Groups C and D, but Group D demonstrated a significantly greater improvement in hematological parameters, with higher packed cell volume (PCV), red blood cell (RBC) count, and hemoglobin (Hb) levels compared to Group C. In contrast, untreated goats in Group B exhibited significantly elevated parasitemia, fever, tachypnea, tachycardia, and reductions in key haematological and serum chemistry values. Conclusion The combination of Aloe vera gel with diminazene aceturate not only enhances haematological recovery but also achieves earlier zero parasitemia compared to diminazene aceturate alone. These findings support the potential of integrating Aloe vera as an adjunct therapy in the management of trypanosomiasis in livestock.

Understanding the function and dysfunction of the brain remains one of the key challenges of our time. However, an overwhelming majority of brain research is carried out in the Global North, by a minority of well-funded and intimately interconnected labs. In contrast, with an estimated one neuroscientist per million people in Africa, news about neuroscience research from the Global South remains sparse. Clearly, devising new policies to boost Africa's neuroscience landscape is imperative. However, the policy must be based on accurate data, which is largely lacking. Such data must reflect the extreme heterogeneity of research outputs across the continent's 54 countries distributed over an area larger than USA, Europe and China combined. Here, we analysed all of Africa's Neuroscience output over the past 21 years. Uniquely, we individually verified in each of 12,326 publications that the work was indeed performed in Africa and led by African-based researchers. This step is critical: previous estimates grossly inflated figures, because many of Africa's high-visibility publications are in fact the result of internationally led collaborations, with most work done outside of Africa. The remaining number of African-led Neuroscience publications was 5,219, on average only ~5 per country and year. From here, we extracted metrics such as the journal and citations, as well as detailed information on funding, international collaborations and the techniques and model systems used. We link these metrics to demographic data and indicators of mobility and economy. For reference, we also extracted the same metrics from 220 randomly selected publications each from the UK, USA, Australia, Japan and Brazil. Our unique dataset allows us to gain accurate and in-depth information on the current state of African Neuroscience research, and to put it into a global context. This in turn allows us to make actionable recommendations on how African research might best be supported in the future. Competing Interest Statement The authors have declared no competing interest. Footnotes * https://github.com/BadenLab/AfricanNeuroscience